Chimeric adenovirus capsid proteins
    1.
    发明申请
    Chimeric adenovirus capsid proteins 审中-公开
    嵌合腺病毒衣壳蛋白

    公开(公告)号:US20050032045A1

    公开(公告)日:2005-02-10

    申请号:US10866013

    申请日:2004-06-10

    Abstract: The present invention relates to chimeric adenovirus capsid proteins comprising a part of or all of an adenovirus capsid protein and a binding partner of a cell-surface binding site on a cell present in gut associated lymphoid tissues (GALT) of a mammal, wherein the chimeric adenovirus capsid protein is capable of binding the cell present in gut associated lymphoid tissues (GALT). In some examples, the adenovirus capsid protein is located on the surface of the adenovirus capsid. The present invention provides adenovirus capsids comprising a chimeric capsid protein. The present invention also provides complexes comprising a chimeric adenovirus capsid protein bound to a cell in GALT. The present invention also provides encapsidation systems and vectors, in particular adenovirus vectors, capable of expressing a chimeric adenovirus capsid protein encompassed within the invention. The present invention also provides viral particles, host cells and compositions comprising such vectors, in particular for use in vaccines, methods of eliciting an immune response and methods for targeted delivery of heterologous proteins, such as antigens, to target cells.

    Abstract translation: 本发明涉及包含哺乳动物肠道相关淋巴组织(GALT)中存在的细胞上的一部分或全部腺病毒衣壳蛋白和细胞表面结合位点的结合配偶体的嵌合腺病毒衣壳蛋白,其中嵌合 腺病毒衣壳蛋白能够结合存在于肠道相关淋巴组织(GALT)中的细胞。 在一些实例中,腺病毒衣壳蛋白位于腺病毒衣壳的表面上。 本发明提供了包含嵌合衣壳蛋白的腺病毒衣壳。 本发明还提供了包含与GALT中的细胞结合的嵌合腺病毒衣壳蛋白的复合物。 本发明还提供能够表达包含在本发明内的嵌合腺病毒衣壳蛋白的包衣系统和载体,特别是腺病毒载体。 本发明还提供病毒颗粒,宿主细胞和包含这种载体的组合物,特别是用于疫苗,引发免疫应答的方法和用于将异源蛋白质例如抗原靶向递送至靶细胞的方法。

    Attenuated influenza NS1 variants
    2.
    发明申请
    Attenuated influenza NS1 variants 有权
    减毒流感NS1变体

    公开(公告)号:US20080050402A1

    公开(公告)日:2008-02-28

    申请号:US11811642

    申请日:2007-06-11

    Abstract: Attenuated influenza virus variants comprising substitutions in NS1 that interfere with viral replication and phosphatidylinositol 3-kinase activation are described. NS1 variant polypeptides, polynucleotides encoding NS1 variant polypeptides, a reverse genetics system for producing attenuated influenza virus NS1 variants, immunogenic compositions comprising live attenuated influenza virus NS1 variants, methods of stimulating an immune response against influenza virus, methods of interfering with influenza virus replication, and methods of treating and preventing influenza virus infection are described.

    Abstract translation: 描述了包含干扰病毒复制和磷脂酰肌醇3-激酶活化的NS1中的取代的减毒流感病毒变体。 NS1变体多肽,编码NS1变体多肽的多核苷酸,用于产生减毒流感病毒NS1变体的反向遗传学系统,包含活减毒流感病毒NS1变体的免疫原性组合物,刺激针对流感病毒的免疫应答的方法,干扰流感病毒复制的方法, 并描述了治疗和预防流感病毒感染的方法。

    Methods for treating and preventing microbial infections
    4.
    发明申请
    Methods for treating and preventing microbial infections 审中-公开
    治疗和预防微生物感染的方法

    公开(公告)号:US20060008466A1

    公开(公告)日:2006-01-12

    申请号:US11127061

    申请日:2005-05-10

    CPC classification number: A61K38/1709 C07K14/4723

    Abstract: Methods for the treatment and prevention of microbial infection, such as infections caused by bacteria, viruses, fungi and parasites are disclosed, as are adjuvants for use with vaccines against such microbes. The methods use porcine β-defensins, such as porcine β-defensin-1 and are particularly useful for treating or preventing infections caused by gram-negative bacteria, such as pertussis.

    Abstract translation: 公开了用于治疗和预防微生物感染的方法,例如由细菌,病毒,真菌和寄生虫引起的感染,以及用于针对这种微生物的疫苗的佐剂。 该方法使用猪β-防御素,例如猪β-防御素-1,并且特别可用于治疗或预防革兰氏阴性细菌如百日咳引起的感染。

Patent Agency Ranking